tiprankstipranks
Conmed (CNMD)
NYSE:CNMD
US Market

Conmed (CNMD) Earnings Dates, Call Summary & Reports

Compare
187 Followers

Earnings Data

Report Date
Apr 23, 2025
TBA Not Confirmed
Period Ending
2025 (Q1)
Consensus EPS Forecast
0.81
Last Year’s EPS
0.79
Same Quarter Last Year
Moderate Buy
Based on 6 Analysts Ratings
---

Earnings Call Summary

Earnings Call Date:Feb 05, 2025
|
% Change Since: -17.39%
|
Next Earnings Date:Apr 23, 2025
Earnings Call Sentiment|Neutral
The earnings call highlighted strong financial performance in certain segments such as General Surgery and AirSeal, with notable improvements in adjusted net income and operating margins. However, challenges such as ongoing supply chain issues in the Orthopedic segment, currency headwinds, and potential tariff impacts were also discussed. The company's focus on resolving these issues and leveraging growth drivers indicates a balanced outlook.
Company Guidance
During the CONMED Fourth Quarter Fiscal Year 2024 Earnings Conference Call, the company reported total sales of $345.9 million for the quarter, marking a 5.8% increase year-over-year as reported, and 6% in constant currency. GAAP net income for the quarter was $33.8 million, with adjusted net income rising by 26.2% to $41.8 million. For the full year, sales reached $1.307 billion, reflecting a 5% increase as reported and 5.3% in constant currency. The Orthopedic business, despite facing supply challenges, grew 2.4% in the fourth quarter and 2.5% for the year. Meanwhile, the General Surgery segment showed robust growth with an 8.7% increase in the fourth quarter and 7.5% for the year in constant currency. The AirSeal product continued to demonstrate strong double-digit growth. Looking ahead to 2025, CONMED projects revenue growth between 4% and 6% in constant currency, with an adjusted EPS guidance range of $4.25 to $4.40, excluding potential impacts from tariffs. The company is focused on resolving supply challenges in its Orthopedic division and capitalizing on key growth drivers such as AirSeal and BioBrace.
Strong Fourth Quarter Sales Growth
Total sales for the fourth quarter were $345.9 million, representing a year-over-year increase of 5.8% as reported and 6% in constant currency.
Significant Improvement in Adjusted Net Income
Adjusted net income of $41.8 million increased 26.2% year-over-year, and adjusted diluted net earnings per share of $1.34 increased 26.4% year-over-year.
General Surgery Business Performance
General Surgery business performed well with constant currency growth of 8.7% in the fourth quarter and 7.5% for the full year.
Strong Performance of AirSeal
AirSeal experienced strong double-digit growth with record capital and disposable sales despite market changes.
Improved Operating Margins
Adjusted operating margin for the full year 2024 improved by 150 basis points over 2023, reaching 15.5%.
---

Conmed (CNMD) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

CNMD Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Apr 23, 20252025 (Q1)
0.81 / -
0.79
Feb 05, 20252024 (Q4)
1.20 / 1.34
1.0626.42% (+0.28)
Oct 30, 20242024 (Q3)
1.02 / 1.05
0.916.67% (+0.15)
Jul 31, 20242024 (Q2)
0.91 / 0.98
0.8318.07% (+0.15)
Apr 24, 20242024 (Q1)
0.74 / 0.79
0.6619.70% (+0.13)
Jan 31, 20242023 (Q4)
1.11 / 1.06
0.42152.38% (+0.64)
Oct 25, 20232023 (Q3)
0.84 / 0.90
0.7716.88% (+0.13)
Jul 26, 20232023 (Q2)
0.79 / 0.83
0.769.21% (+0.07)
Apr 26, 20232023 (Q1)
0.60 / 0.66
0.7-5.71% (-0.04)
Feb 02, 20232022 (Q4)
0.90 / 0.42
1.07-60.75% (-0.65)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---

CNMD Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Feb 05, 2025$74.00$67.36-8.97%
Oct 30, 2024$65.07$68.04+4.56%
Jul 31, 2024$68.66$64.98-5.36%
Apr 24, 2024$69.43$61.39-11.58%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---

FAQ

When does Conmed (CNMD) report earnings?
Conmed (CNMD) is schdueled to report earning on Apr 23, 2025, TBA Not Confirmed.
    What is Conmed (CNMD) earnings time?
    Conmed (CNMD) earnings time is at Apr 23, 2025, TBA Not Confirmed.
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is CNMD EPS forecast?
          CNMD EPS forecast for the fiscal quarter 2025 (Q1) is 0.81.
            ---
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis